持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/06/07 | 3,660 | 3,660 | 3,625 | 3,645 | +15 | +0.4% | 18,300 |
| 2021/06/04 | 3,610 | 3,640 | 3,610 | 3,630 | -5 | -0.1% | 15,500 |
| 2021/06/03 | 3,585 | 3,650 | 3,585 | 3,635 | +40 | +1.1% | 24,400 |
| 2021/06/02 | 3,590 | 3,630 | 3,560 | 3,595 | -25 | -0.7% | 29,100 |
| 2021/06/01 | 3,585 | 3,620 | 3,560 | 3,620 | +50 | +1.4% | 30,300 |
| 2021/05/31 | 3,630 | 3,660 | 3,555 | 3,570 | -85 | -2.3% | 59,600 |
| 2021/05/28 | 3,650 | 3,660 | 3,605 | 3,655 | +55 | +1.5% | 41,300 |
| 2021/05/27 | 3,655 | 3,680 | 3,595 | 3,600 | -70 | -1.9% | 62,100 |
| 2021/05/26 | 3,695 | 3,695 | 3,650 | 3,670 | -35 | -0.9% | 40,300 |
| 2021/05/25 | 3,700 | 3,725 | 3,685 | 3,705 | -5 | -0.1% | 35,800 |
| 2021/05/24 | 3,730 | 3,745 | 3,710 | 3,710 | -20 | -0.5% | 23,700 |
| 2021/05/21 | 3,750 | 3,750 | 3,710 | 3,730 | -5 | -0.1% | 22,000 |
| 2021/05/20 | 3,720 | 3,745 | 3,715 | 3,735 | +10 | +0.3% | 20,800 |
| 2021/05/19 | 3,700 | 3,750 | 3,690 | 3,725 | -15 | -0.4% | 32,200 |
| 2021/05/18 | 3,735 | 3,750 | 3,690 | 3,740 | +35 | +0.9% | 31,300 |
| 2021/05/17 | 3,705 | 3,750 | 3,680 | 3,705 | -50 | -1.3% | 53,600 |
| 2021/05/14 | 3,770 | 3,845 | 3,725 | 3,755 | +40 | +1.1% | 58,700 |
| 2021/05/13 | 3,780 | 3,820 | 3,715 | 3,715 | -65 | -1.7% | 49,000 |
| 2021/05/12 | 3,810 | 3,835 | 3,770 | 3,780 | -70 | -1.8% | 43,200 |
| 2021/05/11 | 3,900 | 3,940 | 3,840 | 3,850 | -90 | -2.3% | 41,900 |
| 2021/05/10 | 3,840 | 3,940 | 3,840 | 3,940 | +85 | +2.2% | 25,000 |
| 2021/05/07 | 3,875 | 3,900 | 3,855 | 3,855 | ±0 | ±0% | 19,300 |
| 2021/05/06 | 3,850 | 3,935 | 3,850 | 3,855 | +50 | +1.3% | 36,800 |
| 2021/04/30 | 3,830 | 3,870 | 3,805 | 3,805 | -15 | -0.4% | 37,300 |
| 2021/04/28 | 3,880 | 3,890 | 3,820 | 3,820 | -60 | -1.5% | 39,200 |
| 2021/04/27 | 3,935 | 3,940 | 3,880 | 3,880 | -40 | -1% | 32,100 |
| 2021/04/26 | 4,010 | 4,010 | 3,920 | 3,920 | -55 | -1.4% | 25,100 |
| 2021/04/23 | 4,005 | 4,035 | 3,975 | 3,975 | -80 | -2% | 20,500 |
| 2021/04/22 | 4,015 | 4,065 | 4,015 | 4,055 | +75 | +1.9% | 45,400 |
| 2021/04/21 | 3,980 | 4,020 | 3,955 | 3,980 | -35 | -0.9% | 45,800 |
| 2021/04/20 | 4,050 | 4,055 | 4,000 | 4,015 | -35 | -0.9% | 44,100 |
| 2021/04/19 | 4,060 | 4,075 | 4,045 | 4,050 | +5 | +0.1% | 23,500 |
| 2021/04/16 | 4,060 | 4,090 | 4,045 | 4,045 | -10 | -0.2% | 15,300 |
| 2021/04/15 | 4,070 | 4,080 | 4,055 | 4,055 | -15 | -0.4% | 15,200 |
| 2021/04/14 | 4,120 | 4,120 | 4,050 | 4,070 | -65 | -1.6% | 26,400 |
| 2021/04/13 | 4,170 | 4,200 | 4,125 | 4,135 | -5 | -0.1% | 28,900 |
| 2021/04/12 | 4,205 | 4,205 | 4,135 | 4,140 | -25 | -0.6% | 49,300 |
| 2021/04/09 | 4,170 | 4,205 | 4,150 | 4,165 | +35 | +0.8% | 29,800 |
| 2021/04/08 | 4,210 | 4,210 | 4,130 | 4,130 | -115 | -2.7% | 43,100 |
| 2021/04/07 | 4,205 | 4,270 | 4,195 | 4,245 | +45 | +1.1% | 30,500 |
| 2021/04/06 | 4,300 | 4,325 | 4,185 | 4,200 | -100 | -2.3% | 45,400 |
| 2021/04/05 | 4,290 | 4,320 | 4,275 | 4,300 | +25 | +0.6% | 30,700 |
| 2021/04/02 | 4,340 | 4,340 | 4,270 | 4,275 | -10 | -0.2% | 14,400 |
| 2021/04/01 | 4,290 | 4,320 | 4,260 | 4,285 | -5 | -0.1% | 26,800 |
| 2021/03/31 | 4,310 | 4,350 | 4,285 | 4,290 | -90 | -2.1% | 45,600 |
| 2021/03/30 | 4,500 | 4,500 | 4,355 | 4,380 | -180 | -3.9% | 45,000 |
| 2021/03/29 | 4,565 | 4,565 | 4,490 | 4,560 | +80 | +1.8% | 73,200 |
| 2021/03/26 | 4,440 | 4,495 | 4,395 | 4,480 | +85 | +1.9% | 36,600 |
| 2021/03/25 | 4,440 | 4,440 | 4,335 | 4,395 | +25 | +0.6% | 47,100 |
| 2021/03/24 | 4,520 | 4,540 | 4,360 | 4,370 | -205 | -4.5% | 51,300 |
851～
900
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
